Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

101
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
101
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

126
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
126
Liver Physiology01:30

Liver Physiology

3.2K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.2K
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

373
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
373
Liver Regeneration01:24

Liver Regeneration

4.0K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.0K
Overview of Skeletal Muscle01:15

Overview of Skeletal Muscle

13.9K
Skeletal muscles are composed of a bundle of muscle fibers and are attached to bones through tendons. Each skeletal muscle fiber is a single muscle cell. The sarcolemma, the plasma membrane of a skeletal muscle cell, consists of a lipid bilayer and glycocalyx that supports muscle fibers. The sarcolemma extends into the muscle cells to form tubular structures called transverse or T-tubules. Each side of the T-tubules consists of a membrane-bound structure called the sarcoplasmic reticulum,...
13.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

The lancet. Gastroenterology & hepatology·2026
Same author

Systemic Drivers and Molecular Mechanisms of Sarcopenia in Aetiology-Specific End-Stage Liver Disease.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement.

Gut·2026
Same author

Major adverse cardiovascular events after liver transplantation: a population cohort analysis of English transplant centres.

EClinicalMedicine·2026
Same author

Physical Frailty and Sarcopenia in Liver Transplantation: How Should They Be Assessed and Addressed?

Transplantation·2025
Same author

Exercise attitudes and practices among adults listed for kidney transplantation: a survey of a diverse patient cohort.

Frontiers in sports and active living·2025

Related Experiment Video

Updated: Dec 8, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

858

Sarcopenia in cirrhosis: A practical overview.

Amritpal Dhaliwal1, Matthew J Armstrong2

  • 1Queen Elizabeth Hospital Birmingham, Birmingham, UK, National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, UK and University of Birmingham, Birmingham, UK a-dhaliwal@live.co.uk.

Clinical Medicine (London, England)
|September 16, 2020
PubMed
Summary

Sarcopenia, or muscle loss in cirrhosis patients, increases health risks. Early recognition and management with high-protein diets and exercise can improve outcomes for liver disease patients.

Keywords:
Sarcopeniacirrhosisliver failuremusclenutrition

More Related Videos

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

980
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.3K

Related Experiment Videos

Last Updated: Dec 8, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

858
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

980
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.3K

Area of Science:

  • Hepatology
  • Geriatrics
  • Sports Medicine

Background:

  • Liver cirrhosis patients face a high risk of sarcopenia, characterized by reduced muscle mass and function.
  • Sarcopenia in cirrhosis is multifactorial, stemming from poor nutrition, protein breakdown, and inactivity, escalating liver-related complications and mortality.
  • This condition significantly impacts patient quality of life and prognosis.

Purpose of the Study:

  • To provide a comprehensive overview of sarcopenia in liver cirrhosis.
  • To discuss the epidemiology, pathogenesis, and assessment of sarcopenia in this patient population.
  • To outline current and potential management strategies for sarcopenia in cirrhosis.

Main Methods:

  • Literature review focusing on sarcopenia in liver cirrhosis.
  • Analysis of epidemiological data and pathogenetic mechanisms.
  • Evaluation of diagnostic tools and therapeutic interventions.

Main Results:

  • Sarcopenia is a prevalent complication of liver cirrhosis, strongly linked to adverse clinical outcomes.
  • Nutritional support and combined exercise regimens show promise in managing sarcopenia.
  • Early detection and intervention are crucial for mitigating sarcopenia's impact.

Conclusions:

  • Sarcopenia is a critical concern in liver cirrhosis management.
  • Tailored interventions, including nutritional and exercise programs, are essential for improving muscle health and patient outcomes.
  • Further research is needed to optimize sarcopenia management strategies in liver disease.